loading

Perché le azioni Lantheus Holdings Inc (LNTH) sono in ribasso?

Abbiamo notato un calo di 5.57% nelle azioni di Lantheus Holdings Inc (LNTH) durante la sessione di negoziazione di 2025-04-10. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-12-18:

Shares of Lantheus Holdings Inc (LNTH) dropped by 26.88% from $76.04 to $55.60 in the trading on Monday, December 18, 2023. The reason why LNTH down today is due to the release of new data from a trial of the experimental prostate cancer treatment, Lu-PNT2002, developed by Lantheus Holdings and Point Biopharma Global Inc. The therapy achieved its primary goal with a median progression-free survival of 9.5 months, compared to six months for an alternative treatment. However, investors were disappointed as Novartis AG's Pluvicto, a similar radioligand therapy, showed better results with a median progression-free survival of 12 months in October.

$7.66
price up icon 0.92%
$102.22
price up icon 0.76%
$27.39
price up icon 0.81%
$8.64
price up icon 1.71%
$289.83
price up icon 1.60%
Capitalizzazione:     |  Volume (24 ore):